[APLS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
01-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -14.91%
YoY- 26.68%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 199,685 172,325 146,377 99,182 94,969 44,846 22,663 327.16%
PBT -37,543 -66,253 -87,153 -140,004 -121,843 -177,496 -167,462 -63.12%
Tax 114 170 1,423 233 194 282 -1,471 -
NP -37,657 -66,423 -88,576 -140,237 -122,037 -177,778 -165,991 -62.83%
Tax Rate - - - - - - - -
Total Cost 237,342 238,748 234,953 239,419 217,006 222,624 188,654 16.55%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -18.86 -38.55 -60.51 -141.39 -128.50 -396.42 -732.43 -91.29%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.30 -0.54 -0.73 -1.17 -1.02 -1.56 -1.50 -65.83%
EPS Diluted -0.30 -0.54 -0.73 -1.17 -1.02 -1.56 -1.50 -65.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.